[Elsevier] Talazoparib plus enzalutamide in men with first-line metastatic castration-resistant prostate cancer (TALAPRO-2): a randomised, placebo-controlled, phase 3 trial

jlmarti0512 Post time Half hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-08-02 03:34
Reward10points

Reply

Use magic Donate Report

All Reply1 Show all posts
markinho_gc Post time 14 min. ago | Show all posts

Waiting for confirmation

If the PDF has not been accepted after 72 hours, the system will automatically adopt it.
Reply

Use magic Donate Report

Senior Member
  • post

  • reply

  • points

    810


Return to the list